Skip to main content
Clinical Trials/IRCT201609026026N4
IRCT201609026026N4Recruiting未知

Evaluating the effect of vitamin D3 supplementation on chronic osteomyelitis treatment and on sleep quality, anxiety and depression in patients with chronic osteomyelitis

Kerman Univesity of Medical Sciences0 sites50 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
16 years to 55 years (—)
Sex
All

Inclusion Criteria

  • Patients with chronic osteomyelitis in the 16-55 age range
  • Exclusion criteria: use of other vitamin D supplements; use of immunosuppressants; history of hypercalcemia or nephrolithiasis; sarcoidosis; kidney disorders requiring dialysis or polycystic kidney disease; cirrhosis; cancer; baseline plasma calcium (corrected for plasma albumin concentration) greater than 10.4 mg/dL or less than 8.4 mg/d

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Kerman Univesity of Medical Sciences

Similar Trials